|Bid||0.00 x 0|
|Ask||0.00 x 0|
|Day's Range||2.16 - 2.30|
|52 Week Range||2.11 - 34.80|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||15.00|
SAN DIEGO, Jan. 10, 2018 /PRNewswire/ -- Aethlon Medical, Inc. (AEMD), a therapeutic technology company focused on unmet needs in global health and biodefense, today announced the appointment of Sabrina Martucci Johnson to its Board of Directors and to its Audit Committee. "We are very pleased to have Sabrina join the Aethlon team," stated Aethlon Medical founder and CEO, Jim Joyce.
In this analysis, my focus will be on developing a perspective on Daré Bioscience Inc’s (NASDAQ:DARE) latest ownership structure, a less discussed, but important factor. A company’s ownership structure isRead More...
SAN DIEGO, Dec. 04, 2017-- Daré Bioscience, Inc., a healthcare company committed to the development and commercialization of innovative products in women’ s reproductive health, today announced that Sabrina ...
Daré Bioscience Inc (NASDAQ:DARE) delivered an ROE of 177.59% over the past 12 months, which is an impressive feat relative to its industry average of 11.31% during the same period.Read More...